These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16704445)

  • 1. Severe infections in thalassaemic patients: prevalence and predisposing factors.
    Rahav G; Volach V; Shapiro M; Rund D; Rachmilewitz EA; Goldfarb A
    Br J Haematol; 2006 Jun; 133(6):667-74. PubMed ID: 16704445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients.
    Gamberini MR; Fortini M; Gilli G; Testa MR; De Sanctis V
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():867-9. PubMed ID: 10091159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center.
    Gamberini MR; Fortini M; De Sanctis V; Gilli G; Testa MR
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():285-91. PubMed ID: 16462713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR; De Sanctis V; Gilli G
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran.
    Karamifar H; Shahriari M; Sadjadian N
    East Mediterr Health J; 2003; 9(1-2):55-60. PubMed ID: 15562733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of the retinal venous tortuosity in chronic anaemic patients affected by beta-thalassaemia major.
    Incorvaia C; Parmeggiani F; Costagliola C; Perri P; D'Angelo S; Sebastiani A
    Eye (Lond); 2003 Apr; 17(3):324-9. PubMed ID: 12724693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac disease in beta-thalassaemia major: Is it reversible?
    Atiq M; Bana M; Ahmed US; Bano S; Yousuf M; Fadoo Z; Khurshid M
    Singapore Med J; 2006 Aug; 47(8):693-6. PubMed ID: 16865210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful desensitization of a case with desferrioxamine hypersensitivity.
    Gülen F; Demir E; Tanaç R; Aydinok Y; Gulen H; Yenigün A; Can D
    Minerva Pediatr; 2006 Dec; 58(6):571-4. PubMed ID: 17093379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
    Gharagozloo M; Moayedi B; Zakerinia M; Hamidi M; Karimi M; Maracy M; Amirghofran Z
    Fundam Clin Pharmacol; 2009 Jun; 23(3):359-65. PubMed ID: 19453758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe bacterial infection in transfusion-dependent patients with thalassemia major.
    Wang SC; Lin KH; Chern JP; Lu MY; Jou ST; Lin DT; Lin KS
    Clin Infect Dis; 2003 Oct; 37(7):984-8. PubMed ID: 13130412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of iron overload and genotype on gonadal function in women with thalassaemia major.
    Skordis N; Gourni M; Kanaris C; Toumba M; Kleanthous M; Karatzia N; Pavlides N; Angastiniotis M
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():292-5. PubMed ID: 16462714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spermatogenesis in young adult patients with beta-thalassaemia major long-term treated with desferrioxamine.
    De Sanctis V; Borsari G; Brachi S; Govoni M; Carandina G
    Georgian Med News; 2008 Mar; (156):74-7. PubMed ID: 18403814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatic abscess due to Yersinia in a child with thalassemia].
    Brunel F; François P; Durand C; Croize J; Jeannoel P
    Pediatrie; 1993; 48(2):159-62. PubMed ID: 8393182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment.
    Dahlui M; Hishamshah MI; Rahman AJ; Aljunid SM
    Singapore Med J; 2009 Aug; 50(8):794-9. PubMed ID: 19710979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensory neural hearing loss in beta-thalassemia major patients treated with deferoxamine.
    Shamsian BS; Aminasnafi A; Moghadassian H; Gachkar L; Arzanian MT; Alavi S; Esfehani H; Garallahi F; Amini R
    Pediatr Hematol Oncol; 2008 Sep; 25(6):502-8. PubMed ID: 18728969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in the prevalence and severity of bone disease in thalassaemia.
    Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe bacterial infections in patients with non-transfusion-dependent thalassemia: prevalence and clinical risk factors.
    Teawtrakul N; Jetsrisuparb A; Sirijerachai C; Chansung K; Wanitpongpun C
    Int J Infect Dis; 2015 Oct; 39():53-6. PubMed ID: 26358855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).
    De Sanctis V; Eleftheriou A; Malaventura C;
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone deficiency (GHD) in adult thalassaemic patients.
    Scacchi M; Danesi L; Cattaneo A; Valassi E; Pecori Giraldi F; Argento C; D'Angelo E; Mirra N; Carnelli V; Zanaboni L; Cappellini MD; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):790-5. PubMed ID: 17608814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marrow proliferation as a cause of hearing loss in beta-thalassaemia major.
    Thio D; Prasad V; Anslow P; Lennox P
    J Laryngol Otol; 2008 Nov; 122(11):1253-6. PubMed ID: 17931455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.